Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition (Q70460439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

review article

1 reference

title

Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

M B Youdim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

P Riederer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

181-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B

11 October 2019

cites work

1 reference

12 December 2020

Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.

1 reference

12 December 2020

Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study

1 reference

12 December 2020

Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem

1 reference

12 December 2020

Some basic aspects of reversible inhibitors of monoamine oxidase-A

1 reference

12 December 2020

New directions in monoamine oxidase A and B selective inhibitors and substrates

1 reference

12 December 2020

Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons

1 reference

12 December 2020

The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain

1 reference

12 December 2020

On the mode of action of L-deprenyl in the human central nervous system

1 reference

12 December 2020

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain

1 reference

12 December 2020

Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors

1 reference

12 December 2020

Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

1 reference

12 December 2020

Brofaromine - a Selective, Reversible, and Short-Acting MAO-A Inhibitor: Review of the Pharmacological and Clinical Findings

1 reference

12 December 2020

Inhibitors of dopamine inactivating systems as antiparkinson drugs

1 reference

12 December 2020

Brain amine concentrations after monoamine oxidase inhibitor administration.

1 reference

12 December 2020

Role of type A and type B monoamine oxidase in the metabolism of released [3H]dopamine from rat striatal slices.

1 reference

12 December 2020

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

12 December 2020

Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans

1 reference

12 December 2020

Reversible, enzyme-activated monoamine oxidase inhibitors: new advances

1 reference

12 December 2020

Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues

1 reference

12 December 2020

Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration

1 reference

12 December 2020

Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys

1 reference

12 December 2020

Does brain 5-HIAA indicate serotonin release or monoamine oxidase activity?

1 reference

12 December 2020

Modification of blood pressure and nictitating membrane response to sympathetic amines by selective monoamine oxidase inhibitors, types A and B, in the cat.

1 reference

12 December 2020

Distinct monoamine oxidase A and B populations in primate brain.

1 reference

12 December 2020

Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens

1 reference

12 December 2020

Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease

1 reference

12 December 2020

Preferential deamination of dopamine by an A type monoamine oxidase in rat brain.

1 reference

12 December 2020

Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.

1 reference

12 December 2020

Potentiation of tyramine pressor responses in conscious rats by reversible inhibitors of monoamine oxidase

1 reference

12 December 2020

Human brain monoamine oxidase: multiple forms and selective inhibitors

1 reference

12 December 2020

(-)Deprenyl in the treatment of Parkinson's disease.

1 reference

12 December 2020

Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine

1 reference

12 December 2020

Isolated chromaffin cells from adrenal medulla contain primarily monoamine oxidase B

1 reference

12 December 2020

Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.

1 reference

12 December 2020

Multiple Forms of Human Brain Mitochondrial Monoamine Oxidase

1 reference

12 December 2020

Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats

1 reference

12 December 2020

In vivo, noradrenaline is a substrate for rat brain monoamine oxidase A and B.

1 reference

12 December 2020

1 reference

12 December 2020

The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions

1 reference

12 December 2020

Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration

1 reference

12 December 2020

Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of rhesus monkey.

1 reference

12 December 2020

Different roles for type A and type B monoamine oxidase in regulating synaptic dopamine at D-1 and D-2 receptors associated with adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation

1 reference

12 December 2020

Will amitriptyline prevent the "cheese" reaction of monoamine-oxidase inhibitors?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01245231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8390270%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference